Manners J M, Nielsen M S
Anaesthesia. 1981 Feb;36(2):157-66. doi: 10.1111/j.1365-2044.1981.tb08717.x.
The Hearse St Thomas' Hospital cardioplegia infusate is one method of preserving the myocardium in the absence of coronary perfusion, during open heart surgery. The infusate contains 16 mmol magnesium/litre and 20 mmol potassium/litre. Peri-operative plasma magnesium levels and urinary excretion of magnesium have been measured, when the infusate was returned to the circulation in 12 patients. The plasma level (+/- SEM) rose to 1.86 mmol/litre (+/- 0.1) 5 minutes after cardiopulmonary bypass commenced, was 1.57 mmol/litre (+/- 0.09) shortly before termination of cardiopulmonary bypass but was normal on the first day after surgery. Urinary excretion of magnesium was 55% of the administered quantity by Day 1 and 77% by the second day. Two patients excreted less than 40% of the administered magnesium within 24 hours probably indicating magnesium depletion. There were no adverse effects from a magnesium load of 16--32 mmol magnesium given during cardiopulmonary bypass.
圣托马斯医院的灵车心脏停搏灌注液是在心脏直视手术中,在无冠状动脉灌注情况下保护心肌的一种方法。该灌注液每升含16毫摩尔镁和20毫摩尔钾。在12例患者中,当灌注液回输到循环系统时,测定了围手术期血浆镁水平和镁的尿排泄量。体外循环开始5分钟后,血浆水平(±标准误)升至1.86毫摩尔/升(±0.1),在体外循环结束前不久为1.57毫摩尔/升(±0.09),但术后第一天正常。到第1天,镁的尿排泄量为给药量的55%,到第二天为77%。两名患者在24小时内排泄的镁少于给药量的40%,这可能表明镁缺乏。在体外循环期间给予16 - 32毫摩尔镁的镁负荷量没有不良反应。